BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9100062)

  • 21. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix.
    Leary J; Jaworski R; Houghton R
    Pathology; 1991 Apr; 23(2):85-9. PubMed ID: 1660591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.
    Cambruzzi E; Zettler CG; Alexandre CO
    Pathol Oncol Res; 2005; 11(2):114-20. PubMed ID: 15999157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
    Sheng Z; Minato H; Sasagawa T; Nakada S; Kinoshita E; Kurose N; Nojima T; Makinoda S
    Int J Clin Exp Pathol; 2013; 6(10):2168-77. PubMed ID: 24133595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix.
    Teshima H; Beaudenon S; Koi S; Katase K; Hasumi K; Masubuchi K; Orth G
    Arch Gynecol Obstet; 1997; 259(4):169-77. PubMed ID: 9271836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization.
    Tase T; Okagaki T; Clark BA; Manias DA; Ostrow RS; Twiggs LB; Faras AJ
    Cancer Res; 1988 Feb; 48(4):993-8. PubMed ID: 2827890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cervical glandular intraepithelial neoplasia topography and the risk of conisation].
    Kałuzyński A; Olszak A; Smolarz B; Kowalczyk A; Kulig A
    Ginekol Pol; 2005 Oct; 76(10):763-9. PubMed ID: 16417091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
    Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
    Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods.
    Cho NH; Joo HJ; Ahn HJ; Jung WH; Lee KG
    Pathol Res Pract; 1998; 194(10):713-20. PubMed ID: 9820868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
    Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
    Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia.
    Tase T; Okagaki T; Clark BA; Twiggs LB; Ostrow RS; Faras AJ
    Int J Gynecol Pathol; 1989; 8(1):8-17. PubMed ID: 2540102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization.
    Gordon AN; Bornstein J; Kaufman RH; Estrada RG; Adams E; Adler-Storthz K
    Gynecol Oncol; 1989 Dec; 35(3):345-8. PubMed ID: 2557270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix.
    Farnsworth A; Laverty C; Stoler MH
    Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age influences the clinical significance of atypical glandular cells on cytology.
    Asciutto KC; Henic E; Forslund O; Bjelkenkrantz K; Borgfeldt C
    Anticancer Res; 2015 Feb; 35(2):913-9. PubMed ID: 25667474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions.
    Moreira MA; Longato-Filho A; Taromaru E; Queiroz G; Jubé LF; Pinto SA; Schmitt FC
    Int J Gynecol Cancer; 2006; 16(2):586-90. PubMed ID: 16681730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization.
    Griffin NR; Dockey D; Lewis FA; Wells M
    Int J Gynecol Pathol; 1991; 10(1):36-43. PubMed ID: 1848834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C; Li Z; Austin RM
    Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma of the cervix and adenocarcinoma of the endometrium: distinction with PCR-mediated detection of HPV DNA.
    Hording U; Daugaard S; Visfeldt J
    APMIS; 1997 Apr; 105(4):313-6. PubMed ID: 9164475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.